
Sign up to save your podcasts
Or


Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.
By John Simboli5
77 ratings
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fibrosis.

3,063 Listeners

1,986 Listeners

1,094 Listeners

2,338 Listeners

945 Listeners

796 Listeners

126 Listeners

337 Listeners

6,135 Listeners

90 Listeners

10,205 Listeners

564 Listeners

151 Listeners

248 Listeners

188 Listeners